Cargando…

Palmitate and Stearate are Increased in the Plasma in a 6-OHDA Model of Parkinson’s Disease

Introduction: Parkinson’s disease (PD) is the second most common neurodegenerative disorder, without any widely available curative therapy. Metabolomics is a powerful tool which can be used to identify unexpected pathway-related disease progression and pathophysiological mechanisms. In this study, m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shah, Anuri, Han, Pei, Wong, Mung-Yee, Chang, Raymond Chuen-Chung, Legido-Quigley, Cristina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6409985/ https://www.ncbi.nlm.nih.gov/pubmed/30781729 http://dx.doi.org/10.3390/metabo9020031

Ejemplares similares

LPGAT1 controls the stearate/palmitate ratio of phosphatidylethanolamine and phosphatidylcholine in sn-1 specific remodeling
por: Xu, Yang, et al.
Publicado: (2022)

Timosaponin A3 Inhibits Palmitate and Stearate through Suppression of SREBP-1 in Pancreatic Cancer
por: Kim, Yumi, et al.
Publicado: (2022)

Stearate‐to‐palmitate ratio modulates endoplasmic reticulum stress and cell apoptosis in non‐B non‐C hepatoma cells
por: Shibasaki, Yasushi, et al.
Publicado: (2018)

Cardiovascular alterations in rats with Parkinsonism induced by 6-OHDA and treated with Domperidone
por: Rodrigues, Laís D., et al.
Publicado: (2019)

Impact of Aging on the 6-OHDA-Induced Rat Model of Parkinson’s Disease
por: Barata-Antunes, Sandra, et al.
Publicado: (2020)

Neuroprotective effect of Spirulina fusiform and amantadine in the 6-OHDA induced Parkinsonism in rats
por: Chattopadhyaya, I, et al.
Publicado: (2015)

Expression of endogenous Mkp1 in 6-OHDA rat models of Parkinson’s disease
por: Collins, Louise M, et al.
Publicado: (2014)

Neuroprotective effect and mechanism of baicalin on Parkinson’s disease model induced by 6-OHDA
por: Tu, Li, et al.
Publicado: (2019)

Effects of low-stearate palm oil and high-stearate lard high-fat diets on rat liver lipid metabolism and glucose tolerance
por: Janssens, Sharon, et al.
Publicado: (2015)

Erratum to: Neuroprotective effect of Spirulina fusiform and amantadine in the 6-OHDA induced Parkinsonism in rats
por: Chattopadhyaya, I., et al.
Publicado: (2015)

Glucose Homeostasis Is Not Affected in a Murine Model of Parkinson’s Disease Induced by 6-OHDA
por: Gomes, Felipe Azevedo, et al.
Publicado: (2019)

6-OHDA-Induced Changes in Colonic Segment Contractility in the Rat Model of Parkinson's Disease
por: Murillo, Maria Del Pilar, et al.
Publicado: (2023)

Acyl-Ghrelin Attenuates Neurochemical and Motor Deficits in the 6-OHDA Model of Parkinson’s Disease
por: Rees, Daniel, et al.
Publicado: (2022)

Identification of Bilateral Changes in TID1 Expression in the 6-OHDA Rat Model of Parkinson's Disease
por: Proft, Juliane, et al.
Publicado: (2011)

Dopamine Transporter Loss in 6-OHDA Parkinson’s Model Is Unmet by Parallel Reduction in Dopamine Uptake
por: Chotibut, Tanya, et al.
Publicado: (2012)

Cell Fate Analysis of Embryonic Ventral Mesencephalic Grafts in the 6-OHDA Model of Parkinson's Disease
por: Neto, Sonya Carvalho, et al.
Publicado: (2012)

Neuroprotective activity of Stereospermum suaveolens DC against 6-OHDA induced Parkinson's disease model
por: Shalavadi, M. H., et al.
Publicado: (2012)

Intrastriatal Grafting of Chromospheres: Survival and Functional Effects in the 6-OHDA Rat Model of Parkinson's Disease
por: Boronat-García, Alejandra, et al.
Publicado: (2016)

Gait Analysis for Early Detection of Motor Symptoms in the 6-OHDA Rat Model of Parkinson's Disease
por: Boix, Jordi, et al.
Publicado: (2018)

Botulinum Toxin A Ameliorates Neuroinflammation in the MPTP and 6-OHDA-Induced Parkinson’s Disease Models
por: Ham, Hyeon Joo, et al.
Publicado: (2022)

The Relationship between Iron and LRRK2 in a 6-OHDA-Induced Parkinson’s Disease Model
por: Jia, Ruru, et al.
Publicado: (2023)

Abscisic acid ameliorates motor disabilities in 6-OHDA-induced mice model of Parkinson's disease
por: Shabani, Mohammad, et al.
Publicado: (2023)

Changes in Day/Night Activity in the 6-OHDA-Induced Experimental Model of Parkinson’s Disease: Exploring Prodromal Biomarkers
por: Requejo, Catalina, et al.
Publicado: (2020)

Striatal Injury with 6-OHDA Transiently Increases Cerebrospinal GFAP and S100B
por: Batassini, Cristiane, et al.
Publicado: (2015)

Development of pH sensitive polymeric nanoparticles of erythromycin stearate
por: Bhadra, Sulekha, et al.
Publicado: (2016)

Oleate but not stearate induces the regulatory phenotype of myeloid suppressor cells
por: Wu, Hao, et al.
Publicado: (2017)

Starch Retrogradation in Rice Cake: Influences of Sucrose Stearate and Glycerol
por: Oh, Seon-Min, et al.
Publicado: (2020)

Oil Adsorption Kinetics of Calcium Stearate-Coated Kapok Fibers
por: Blaquera, Aimee Lorraine M., et al.
Publicado: (2023)

T-Lymphocyte Deficiency Exacerbates Behavioral Deficits in the 6-OHDA Unilateral Lesion Rat Model for Parkinson’s Disease
por: Wheeler, Christopher J, et al.
Publicado: (2014)

Protective effect of methanolic extract of Garcinia indica fruits in 6-OHDA rat model of Parkinson's disease
por: Antala, Bhaveshkumar V., et al.
Publicado: (2012)

Alterations of the nigrostriatal pathway in a 6-OHDA rat model of Parkinson’s disease evaluated with multimodal MRI
por: Perlbarg, Vincent, et al.
Publicado: (2018)

Fraternine, a Novel Wasp Peptide, Protects against Motor Impairments in 6-OHDA Model of Parkinsonism
por: Biolchi, Andréia Mayer, et al.
Publicado: (2020)

Substantia Nigra Hyperechogenicity Reflects the Progression of Dopaminergic Neurodegeneration in 6-OHDA Rat Model of Parkinson’s Disease
por: Zhang, Siyan, et al.
Publicado: (2020)

Chaperone Sigma1R mediates the neuroprotective action of afobazole in the 6-OHDA model of Parkinson’s disease
por: Voronin, Mikhail V., et al.
Publicado: (2019)

Dihydroisotanshinone I and BMAL-SIRT1 Pathway in an In Vitro 6-OHDA-Induced Model of Parkinson’s Disease
por: Su, Hui-Chen, et al.
Publicado: (2023)

Improvement of Inhalation Profile of DPI Formulations by Carrier Treatment with Magnesium Stearate
por: Hazare, Shruti, et al.
Publicado: (2009)

Immobilized lipase catalyzing glucose stearate synthesis and their surfactant properties analysis
por: Sebatini, A. Maria, et al.
Publicado: (2016)

Lupeol Stearate Accelerates Healing and Prevents Recurrence of Gastric Ulcer in Rodents
por: Somensi, Lincon Bordignon, et al.
Publicado: (2022)

Pharmacological, Biochemical and Immunological Studies on Protective Effect of Mangiferin in 6-Hydroxydopamine (6-OHDA)-Induced Parkinson’s Disease in Rats
por: Tiwari, Prafulla Chandra, et al.
Publicado: (2021)

Pilose Antler Extracts (PAEs) Protect against Neurodegeneration in 6-OHDA-Induced Parkinson's Disease Rat Models
por: Li, Chaohua, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4btn1f86h248uafi6nkrfq14k1